查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790474

美國臨床試驗設備和輔助解決方案市場規模、佔有率和趨勢分析報告：按類型、階段和細分市場預測，2025 年至 2033 年

U.S. Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Type (Sourcing, Supply/Logistics, Service), By Phase (Phase I, II, III, IV), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

美國臨床試驗設備和輔助解決方案市場規模預計在 2024 年達到 10.5 億美元，預計到 2033 年將達到 20.6 億美元，2025 年至 2033 年的複合年成長率為 7.83%。

這一成長是由日益複雜的臨床試驗通訊協定推動的，這增加了對設備物流精準性、設備校準以及研究相關物資及時分發的需求。申辦方面臨著遵守法規和研究時間表的壓力，這導致他們越來越依賴專門從事輔助供應鏈管理、配套、設備租賃和逆向物流的第三方供應商。

美國的臨床試驗正日益分散，推動了對設備和輔助解決方案的需求。傳統的集中式臨床試驗正在被混合和完全分散的模式所取代或補充，需要在參與者家中和現場進行廣泛的物流協調和專門設備部署。這種轉變需要直接面向患者 (DTP) 的供應鏈、行動醫療套件、連網醫療設備和必須符合 FDA 標準的家庭診斷設備。例如，遠端心電圖監測儀、穿戴式生物感測器和數位肺計量計的興起需要能夠遠端管理設備校準、患者培訓和數據整合的輔助提供者。支援多個遠端站點和參與者的物流複雜性需要即時追蹤、自動補給系​​統和強大的逆向物流。所有這些都刺激了對提供針對分散試驗量身定做的端到端支援的輔助解決方案供應商的投資。

精準醫療和複雜治療領域（如腫瘤學、神經病學和基因治療）臨床試驗的激增也推動了美國臨床試驗設備和輔助解決方案產業的成長。這些試驗通常需要高度專業化的設備，例如細胞治療輸液幫浦、客製化檢體採集套件和溫控藥物傳輸裝置。輔助設備供應商需要處理專門的包裝、設備預處理和維護通訊協定，以保持溫度和時間敏感型供應的完整性。隨著通訊協定變得越來越複雜，包括生物標記評估、數位端點和縱向採樣，輔助服務的標準化和擴充性變得至關重要。為此，供應商正在整合雲端基礎管理、自動標籤和合規性追蹤工具，以簡化流程並滿足贊助商和 CRO 日益成長的需求。與先進治療試驗的這種合作正在將市場從基礎物流擴展到高價值的臨床試驗支援基礎設施。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章美國臨床試驗設備和輔助解決方案市場：變數、趨勢和範圍

  • 市場體系展望
  • 美國臨床試驗設備與輔助解決方案市場動態
  • 技術格局
  • 定價模式分析
  • 美國臨床試驗設備與輔助解決方案市場：分析工具

第4章：美國臨床試驗設備和輔助解決方案市場：類型估計和趨勢分析

  • 細分儀表板
  • 美國臨床試驗設備與輔助解決方案市場類型變化分析
  • 美國臨床試驗設備和輔助解決方案市場規模和趨勢分析（按類型）（2021-2033）
  • 採購
    • 採購
    • 租賃
  • 供應/物流
    • 運輸
    • 包裝
    • 其他
  • 服務
    • 校準
    • 設備維護
    • 其他
  • 其他

第5章美國臨床試驗設備和輔助解決方案市場：階段估計和趨勢分析

  • 細分儀表板
  • 美國臨床試驗設備和輔助解決方案市場的階段波動分析
  • 美國臨床試驗設備和輔助解決方案市場規模和趨勢分析（按階段，2021-2033）
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第6章 競爭態勢

  • 公司分類
    • 市場領導者
    • 新興企業
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • Ancillare, LP
    • Imperial CRS, Inc.
    • Woodley Equipment Company Ltd.
    • Thermo Fisher Scientific, Inc.
    • Parexel International（MA）Corporation
    • Emsere（formerly MediCapital Rent）
    • Quipment SAS
    • IRM
    • Marken（UPS-United Parcel Service）
    • Myonex
    • Yourway
Product Code: GVR-4-68040-686-6

Market Size & Trends:

The U.S. clinical trial equipment & ancillary solutions market size was estimated at USD 1.05 billion in 2024 and is projected to reach USD 2.06 billion by 2033, growing at a CAGR of 7.83% from 2025 to 2033. The growth is due to the increasing complexity of clinical trial protocols, which has heightened the need for precision in equipment logistics, device calibration, and timely distribution of trial-related supplies. Sponsors are under growing pressure to meet tight regulatory and study timelines, which in turn has increased reliance on third-party providers specializing in ancillary supply chain management, kitting, equipment leasing, and reverse logistics.

The increasing decentralization of clinical trials in the U.S. is a major driver for the demand for equipment and ancillary solutions. Traditional centralized trials are being replaced or supplemented by hybrid and fully decentralized models, which require extensive logistical coordination and specialized equipment deployment at participants' homes or local sites. This shift has created a need for direct-to-patient (DTP) supply chains, mobile health kits, connected medical devices, and home-use diagnostics that must be compliant with FDA standards. For instance, the rise of remote ECG monitors, wearable biosensors, and digital spirometers has necessitated ancillary providers capable of managing device calibration, patient training, and data integration remotely. The logistical complexity of supporting multiple remote sites and participants requires real-time tracking, automated resupply systems, and robust reverse logistics - all of which are fueling investments into ancillary solution providers offering end-to-end support tailored for decentralized trials.

The surge in precision medicine and complex therapeutic areas such as oncology, neurology, and gene therapy trials is also propelling the growth of the clinical trial equipment & ancillary solutions industry in the U.S. These trials often demand highly specific equipment like infusion pumps for cellular therapies, customized specimen collection kits, and temperature-controlled drug delivery devices. Ancillary providers are expected to handle specialized packaging, pre-conditioning of equipment, and maintenance protocols to preserve the integrity of temperature- and time-sensitive supplies. The increase in protocol complexity - including biomarker assessments, digital endpoints, and longitudinal sampling - has made the standardization and scalability of ancillary services critical. In response, vendors are integrating cloud-based inventory management, automated labeling, and compliance-tracking tools to streamline processes and meet the heightened demands of sponsors and CROs. This alignment with advanced therapeutic trials is expanding the market beyond basic logistics into high-value clinical trial support infrastructure.

U.S. Clinical Trial Equipment & Ancillary Solutions Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. clinical trial equipment & ancillary solutions market report based on type, and phase:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Sourcing
    • Procurement
    • Equipment
    • Ancillaries
    • Rental
    • Equipment
    • Ancillaries
  • Supply/Logistics
    • Transportation
    • Packaging
    • Others
  • Service
    • Calibrations
    • Equipment servicing
    • Others
  • Others
  • Phase Outlook (Revenue, USD Million, 2021 - 2033)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Clinical Trial Equipment & Ancillary Solutions Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. U.S. Clinical Trial Equipment & Ancillary Solutions Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. U.S. Clinical Trial Equipment & Ancillary Solutions Market: Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis

Chapter 4. U.S. Clinical Trial Equipment & Ancillary Solutions Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Clinical Trial Equipment & Ancillary Solutions Market Type Movement Analysis
  • 4.3. U.S. Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Sourcing
    • 4.4.1. Sourcing Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.4.2. Procurement
      • 4.4.2.1. Procurement Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.2. Equipment
        • 4.4.2.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.3. Ancillaries
        • 4.4.2.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Rental
      • 4.4.3.1. Rental Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Equipment
        • 4.4.3.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Ancillaries
        • 4.4.3.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Supply/Logistics
    • 4.5.1. Supply/Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Transportation
      • 4.5.2.1. Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Packaging
      • 4.5.3.1. Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Service
    • 4.6.1. Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Calibrations
      • 4.6.2.1. Calibrations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Equipment servicing
      • 4.6.3.1. Equipment Servicing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Clinical Trial Equipment & Ancillary Solutions Market: Phase Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Clinical Trial Equipment & Ancillary Solutions Market Phase Movement Analysis
  • 5.3. U.S. Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Phase, 2021 to 2033 (USD Million)
  • 5.4. Phase I
    • 5.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Phase II
    • 5.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Phase III
    • 5.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Phase IV
    • 5.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
    • 6.1.1. Market Leaders
    • 6.1.2. Emerging Players
  • 6.2. Company Market Share/Assessment Analysis, 2024
  • 6.3. Company Profiles
    • 6.3.1. Ancillare, LP
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Service benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. Imperial CRS, Inc.
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Service benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. Woodley Equipment Company Ltd.
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Service benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Thermo Fisher Scientific, Inc.
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Service benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Parexel International (MA) Corporation
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Service benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Emsere (formerly MediCapital Rent)
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Service benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Quipment SAS
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Service benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. IRM
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Service benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Marken (UPS-United Parcel Service)
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Service benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Myonex
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Service benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Yourway
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Service benchmarking
      • 6.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 3 U.S. clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 4 U.S. clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 US clinical trial equipment & ancillary solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 US clinical trial equipment & ancillary solutions market dynamics
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 U.S. clinical trial equipment & ancillary solutions market type outlook: Segment dashboard
  • Fig. 22 U.S. clinical trial equipment & ancillary solutions market, by type segment: Market share, 2024 & 2033
  • Fig. 23 Sourcing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Procurement market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Rental market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Supply/Logistics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Transportation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Packaging market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Service market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Calibrations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Equipment servicing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 US clinical trial equipment & ancillary solutions market phase outlook: Segment dashboard
  • Fig. 39 US clinical trial equipment & ancillary solutions market, by phase segment: Market share, 2024 & 2033
  • Fig. 40 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Phase IV market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Market participant categorization
  • Fig. 45 Heat map analysis